Table 2

Results of multivariate analysis

VariableβSE (β)Odds ratio (95% CI)
*β = −4.638; SE (β) = 0.739; goodness-of-fit χ2 = 0.011; df = 2; P = 0.995; area under the ROC curve = 0.680.
†β = −6.073; SE (β) = 0.795; goodness-of-fit χ2 = 7.357; df = 8; P = .499; area under the ROC curve = 0.777; sensitivity 68.5%; specificity 68.7%; correct classification 68.7%.
‡β = −6.402; SE (β) = 0.835; goodness-of-fit χ2 = 3.73; df = 8; P = .893; area under the ROC cirve = 0.858; sensitivity 71.4%; specificity 83.9%; correct classification 83.6%.
DCHS v other lacunar syndromes*
    Limb weakness1.7960.7386.03 (1.42 to 25.59)
    Absence of limitation at discharge1.0450.3582.84 (1.41 to 5.73)
DCHS v non-lacunar stroke
    Demographic, vascular risk factors and clinical data†
        Absence of limitation at discharge1.7990.3596.04 (2.99 to 12.22)
        Limb weakness1.7400.7385.70 (1.34 to 24.23)
        Diabetes mellitus0.9760.3752.65 (1.27 to 5.53)
        Hypertension0.7580.3652.13 (1.04 to 4.36)
        Female sex−0.9910.3860.37 (0.17 to 0.79)
    Demographic, vascular risk, clinical, and topographic data‡
        Corona radiata2.4670.78011.79 (2.56 to 54.33)
        Internal capsule2.3050.41910.03 (4.41 to 22.78)
        Absence of limitation at discharge1.5970.3924.94 (2.29 to 10.66)
        Pons1.5690.5464.80 (1.65 to 14.01)
        Limb weakness1.5120.7554.54 (1.03 to 19.92)
        Diabetes mellitus0.8970.4032.45 (1.11 to 5.40)
        Hypertension0.7670.3872.15 (1.01 to 4.60)
        Female sex−0.8070.4060.45 (0.20 to 0.99)
        Basal ganglia−2.8381.0510.06 (0.01 to 0.46)